Table 4 Hepatologists’ attitude towards the use of combination tools for diagnosis of significant fibrosis and cirrhosis
Variable | Patients (n = 573) |
|---|---|
Do you use combinations of serum biomarkers and radiological methods for non-invasive assessment of hepatic fibrosis? % | |
 Extremely likely (100%) | 13.20 |
 Very likely (75%) | 26.17 |
 Moderately likely (50%) | 15.88 |
 Slightly likely (25%) | 23.27 |
 Not at all likely (0%) | 21.48 |
Do you think combinations of methods are more beneficial for non-invasive assessment of hepatic fibrosis than using a single method? % | |
 Extremely likely (100%) | 31.1 |
 Very likely (75%) | 34 |
 Moderately likely (50%) | 21.70 |
 Slightly likely (25%) | 10.29 |
 Not at all likely (0%) | 2.91 |
Which method do you think is easier to use for the assessment of hepatic fibrosis? % | |
 Liver biopsy | 5.37 |
 Radiological methods | 40.27 |
 Serum biomarkers | 24.16 |
 Combination of non-invasive methods | 30.20 |